SoloVital - 688046 - 08/27/2024
Issuing Office: Center for Drug Evaluation and Research (CDER) United States WARNING LETTER August 27, 2024 RE: 688046 Dear Mr. German Alegre: This letter is to advise you that the United States Food and Drug Administration (FDA) reviewed your website at …